Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Pembrolizumab + Tamoxifen
Sponsor: Mediclinic Middle East